A group of government, academic, and charitable entities in Canada has committed funding to build a new facility to research and develop next-generation medical isotopes and radiopharmaceuticals.
Construction for the Institute for Advanced Medical Isotopes (IAMI) is valued at $31.8 million Canadian ($24 million U.S.), and the institute will be located on the campus of the University of British Columbia's Tri-University Meson Facility (TRIUMF). With additional equipment and philanthropic funding, the total value of the IAMI project will be more than $50 million Canadian ($38 million U.S.).
IAMI's goals will include the following:
- Secure isotope supplies
- Develop next-generation cancer therapies
- Accelerate global drug development
- Improve health outcomes for Canadians
- Provide certified infrastructure for isotope production
